1. Home
  2. CDLX vs AMRN Comparison

CDLX vs AMRN Comparison

Compare CDLX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$3.48

Market Cap

20.3M

Sector

Technology

ML Signal

HOLD

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$13.56

Market Cap

287.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLX
AMRN
Founded
2008
1989
Country
United States
Ireland
Employees
224
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3M
287.9M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
CDLX
AMRN
Price
$3.48
$13.56
Analyst Decision
Hold
Strong Sell
Analyst Count
2
1
Target Price
$2.25
★ $12.00
AVG Volume (30 Days)
32.2K
★ 52.0K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
50.13
★ 55.00
EPS
N/A
★ N/A
Revenue
★ $233,273,000.00
$181,104,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.82
$1.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.22
52 Week Low
$0.55
$12.96
52 Week High
$6.40
$20.90

Technical Indicators

Market Signals
Indicator
CDLX
AMRN
Relative Strength Index (RSI) 35.18 42.48
Support Level $0.86 $13.32
Resistance Level $4.42 $14.50
Average True Range (ATR) 0.21 0.37
MACD -0.06 -0.02
Stochastic Oscillator 1.13 32.37

Price Performance

Historical Comparison
CDLX
AMRN

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Share on Social Networks: